共 513 条
[1]
Bennett JM(1985)Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British cooperative group Ann Intern Med 103 620-625
[2]
Catovsky D(2016)The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia Blood. 127 2391-2405
[3]
Daniel MT(2008)Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs Blood. 112 45-52
[4]
Flandrin G(2019)Trends of incidence and survival of patients with chronic myelomonocytic leukemia between 1999 and 2014: a comparison between Swiss and American population-based cancer registries Cancer Epidemiol 59 51-57
[5]
Galton DA(2013)Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia Transfuze a Hematologie Dnes 19 191-206
[6]
Gralnick HR(2013)Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: prevalence, clinical correlates, and prognostic relevance Am J Hematol 88 201-e385
[7]
Arber DA(2014)ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients Leukemia. 28 2206-2387
[8]
Orazi A(2016)Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia Blood Cancer Journal 6 e385-2198
[9]
Hasserjian R(2016)Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents Nat Commun 7 10767-1545
[10]
Thiele J(2016)When clinical heterogeneity exceeds genetic heterogeneity: thinking outside the genomic box in chronic myelomonocytic leukemia Blood 128 2381-e80